RxDoctor Payments Data

Brandi Mays, APRN

Family · Blytheville, ARNPI 1811462138

Payments from drug & device makers

$488in general payments, 2019–2025

Across 30 payments — averaging $16.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$188
  • Boston Scientific$120
  • Sanofi Pasteur Inc.$47
  • AstraZeneca$44
  • Boehringer Ingelheim$28
  • Shield Therapeutics Inc$19
  • plus $42 from 3 others

What the payments were for

  • Food & beverage$488100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$488 in reported general payments places this provider in the 55th percentile of 2,103 family providers in Arkansas.

See all family providers in Arkansas

Medicare billing

Part B allowed, 2024
$1,965
Medicare patients
34
Services billed
182

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide27$36,168
JardianceEmpagliflozin33$25,136
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$23,765
Spiriva RespimatTiotropium Bromide12$9,166
Breo ElliptaFluticasone/Vilanterol16$7,238
Albuterol Sulfate HfaAlbuterol Sulfate47$1,185
Atorvastatin Calcium130$882
Pantoprazole Sodium51$801
Omeprazole68$779
Gabapentin61$551
Losartan Potassium58$526
Potassium Chloride29$477
Amlodipine Besylate107$473
Tamsulosin Hcl40$438
Simvastatin50$408

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$14$36,16827 claims
Boehringer IngelheimJardiance, Spiriva Respimat$28$34,30245 claims
GSKTrelegy Ellipta, Breo Ellipta$188$31,00341 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,103 family providers in Arkansas.

Other family in Blytheville

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →